Validation of the Bluebelle Wound Healing Questionnaire for assessment of surgical-site infection in closed primary wounds after hospital discharge.


Journal

The British journal of surgery
ISSN: 1365-2168
Titre abrégé: Br J Surg
Pays: England
ID NLM: 0372553

Informations de publication

Date de publication:
02 2019
Historique:
received: 02 07 2018
revised: 13 08 2018
accepted: 05 09 2018
pubmed: 18 12 2018
medline: 30 7 2019
entrez: 18 12 2018
Statut: ppublish

Résumé

Accurate assessment of surgical-site infection (SSI) is crucial for surveillance and research. Self-reporting patient measures are needed because current SSI tools are limited for assessing patients after leaving hospital. The Bluebelle Wound Healing Questionnaire (WHQ) was developed for patient or observer completion; this study tested its acceptability, scale structure, reliability and validity in patients with closed primary wounds after abdominal surgery. Patients completed the WHQ (self-assessment) within 30 days after leaving hospital and returned it by post. Healthcare professionals completed the WHQ (observer assessment) by telephone or face-to-face. Questionnaire response rates and patient acceptability were assessed. Factor analysis and Cronbach's α examined scale structure and internal consistency. Test-retest and self- versus observer reliability assessments were performed. Sensitivity and specificity for SSI discrimination against a face-to-face reference diagnosis (using Centers for Disease Control and Prevention criteria) were examined. Some 561 of 792 self-assessments (70·8 per cent) and 597 of 791 observer assessments (75·5 per cent) were completed, with few missing data or problems reported. Data supported a single-scale structure with strong internal consistency (α greater than 0·8). Reliability between test-retest and self- versus observer assessments was good (κ 0·6 or above for the majority of items). Sensitivity and specificity for SSI discrimination was high (area under the receiver operating characteristic (ROC) curve 0·91). The Bluebelle WHQ is acceptable, reliable and valid with a single-scale structure for postdischarge patient or observer assessment of SSI in closed primary wounds.

Sections du résumé

BACKGROUND
Accurate assessment of surgical-site infection (SSI) is crucial for surveillance and research. Self-reporting patient measures are needed because current SSI tools are limited for assessing patients after leaving hospital. The Bluebelle Wound Healing Questionnaire (WHQ) was developed for patient or observer completion; this study tested its acceptability, scale structure, reliability and validity in patients with closed primary wounds after abdominal surgery.
METHODS
Patients completed the WHQ (self-assessment) within 30 days after leaving hospital and returned it by post. Healthcare professionals completed the WHQ (observer assessment) by telephone or face-to-face. Questionnaire response rates and patient acceptability were assessed. Factor analysis and Cronbach's α examined scale structure and internal consistency. Test-retest and self- versus observer reliability assessments were performed. Sensitivity and specificity for SSI discrimination against a face-to-face reference diagnosis (using Centers for Disease Control and Prevention criteria) were examined.
RESULTS
Some 561 of 792 self-assessments (70·8 per cent) and 597 of 791 observer assessments (75·5 per cent) were completed, with few missing data or problems reported. Data supported a single-scale structure with strong internal consistency (α greater than 0·8). Reliability between test-retest and self- versus observer assessments was good (κ 0·6 or above for the majority of items). Sensitivity and specificity for SSI discrimination was high (area under the receiver operating characteristic (ROC) curve 0·91).
CONCLUSION
The Bluebelle WHQ is acceptable, reliable and valid with a single-scale structure for postdischarge patient or observer assessment of SSI in closed primary wounds.

Identifiants

pubmed: 30556594
doi: 10.1002/bjs.11008
pmc: PMC6457211
doi:

Types de publication

Journal Article Validation Study

Langues

eng

Pagination

226-235

Subventions

Organisme : Medical Research Council
ID : MR/S001751/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0802413
Pays : United Kingdom
Organisme : Medical Research Council (MRC)
ID : MR/K025643/1
Pays : International
Organisme : Medical Research Council
ID : MR/K025643/1
Pays : United Kingdom
Organisme : Department of Health
ID : NIHR300175
Pays : United Kingdom
Organisme : Department of Health
ID : 12/200/04
Pays : United Kingdom

Investigateurs

Rhiannon Macefield (R)
Jane Blazeby (J)
Barnaby Reeves (B)
Sara Brookes (S)
Kerry Avery (K)
Chris Rogers (C)
Mark Woodward (M)
Nicky Welton (N)
Leila Rooshenas (L)
Jonathan Mathers (J)
Andrew Torrance (A)
Anne Pullyblank (A)
Robert Longman (R)
Richard Lovegrove (R)
Tim Draycott (T)
Thomas Pinkney (T)
Rachael Gooberman-Hill (R)
Jenny Donovan (J)
Joanna Coast (J)
Melanie Calvert (M)
Natalie Blencowe (N)
Lazaros Andronis (L)
Dimitrios Siassakos (D)
Caroline Pope (C)
Madeleine Clout (M)
Kate Ashton (K)
Lucy Ellis (L)
Christel McMullan (C)
Rosie Harris (R)
Daisy Elliott (D)
Jo Dumville (J)
Benjamin Waterhouse (B)
Sean Strong (S)
William Seligman (W)
Lloyd Rickard (L)
Samir Pathak (S)
Anwar Owais (A)
Jamie O'Callaghan (J)
Stephen O'Brien (S)
Dmitri Nepogodiev (D)
Khaldoun Nadi (K)
Charlotte Murkin (C)
Tonia Munder (T)
Tom Milne (T)
David Messenger (D)
Matthew Mason (M)
Morwena Marshall (M)
Jessica Lloyd (J)
Jeffrey Lim (J)
Kathryn Lee (K)
Vijay Korwar (V)
Daniel Hughes (D)
George Hill (G)
Mohammed Hamdan (M)
Hannah Gould Brown (HG)
James Glasbey (J)
Caroline Fryer (C)
Simon Davey (S)
David Cotton (D)
Benjamin Byrne (B)
Oliver Brown (O)
Katarzyna Bera (K)
Joanne Bennett (J)
Richard Bamfor (R)
Danya Bakhbakhi (D)
Muhammad Atif (M)
Elizabeth Armstrong (E)
Piriyankan Ananthavarathan (P)

Informations de copyright

© 2018 The Authors. BJS published by John Wiley & Sons Ltd on behalf of BJS Society Ltd.

Références

J Hosp Infect. 2014 Jan;86(1):24-33
pubmed: 24268456
J Am Coll Surg. 2016 Aug;223(2):259-270.e2
pubmed: 27188832
Health Technol Assess. 2011 Sep;15(30):1-156, iii-iv
pubmed: 21884656
J Clin Epidemiol. 2010 Jul;63(7):737-45
pubmed: 20494804
JMIR Mhealth Uhealth. 2016 Sep 28;4(3):e113
pubmed: 27683059
J Hosp Infect. 2013 Feb;83(2):87-91
pubmed: 23332352
J Infect Prev. 2017 Jul;18(4):170-179
pubmed: 28989524
Trials. 2017 Aug 29;18(1):401
pubmed: 28851399
Am J Infect Control. 2008 Jun;36(5):309-32
pubmed: 18538699
BMC Infect Dis. 2006 Nov 27;6:170
pubmed: 17129368
J Hosp Infect. 2009 Jul;72(3):243-50
pubmed: 19446918
J Hosp Infect. 2005 Jun;60(2):93-103
pubmed: 15866006
PLoS One. 2014 Dec 01;9(12):e114016
pubmed: 25436912
J Hosp Infect. 2013 Feb;83(2):83-6
pubmed: 23332350
BMJ Open. 2016 Sep 22;6(9):e012635
pubmed: 27660321
Lancet. 1986 Feb 8;1(8476):311-3
pubmed: 2868173
Health Technol Assess. 2001;5(22):1-194
pubmed: 11532239

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH